Also trades as: SLXN (NASDAQ) · $vol 1M
SLXNW Earnings
Silexion Therapeutics Ltd.
1W: -39.4%
1M: -47.4%
3M: -81.8%
YTD: -84.6%
1Y: -80.1%
$0.01
-0.00 (-21.05%)
Weekly Expected Move ±45.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Next Earnings
2026-11-18
EPS Estimate
$-7.10
Range: $-7.10 - $-7.10
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | annual | 2027-12-31 | $-22.10 | $-20.25 | ▲ 1.85 | $— | $— |
| 2026-09-22 | annual | 2026-12-31 | $-49.90 | $-48.45 | ▲ 1.45 | $— | $— |
| 2026-08-21 | quarter | 2026-12-30 | $-7.30 | $-7.10 | ▲ 0.20 | $— | $— |
| 2026-08-21 | quarter | 2026-09-30 | $-15.20 | $-9.10 | ▲ 6.10 | $— | $— |
| 2026-08-20 | annual | 2027-12-31 | $-20.30 | $-22.10 | ▼ 1.80 | $— | $— |
| 2026-08-20 | annual | 2029-12-31 | $-15.30 | $-17.00 | ▼ 1.70 | $— | $— |
| 2026-08-20 | annual | 2030-12-31 | $-0.30 | $-1.60 | ▼ 1.30 | $34,989,000 | $34,989,000 |
| 2026-08-20 | annual | 2028-12-31 | $-15.80 | $-17.50 | ▼ 1.70 | $— | $— |
| 2026-08-20 | annual | 2026-12-31 | $-53.10 | $-49.90 | ▲ 3.20 | $— | $— |
| 2026-08-14 | quarter | 2026-12-30 | $— | $-7.30 | ▼ 7.30 | $— | $— |
| 2026-07-01 | annual | 2026-12-31 | $-49.30 | $-53.10 | ▼ 3.80 | $— | $— |
| 2026-06-29 | quarter | 2026-06-30 | $-13.10 | $-21.20 | ▼ 8.10 | $— | $— |
| 2026-06-29 | annual | 2030-12-31 | $-3.90 | $-0.30 | ▲ 3.60 | $34,989,000 | $34,989,000 |
| 2026-06-29 | annual | 2027-12-31 | $-22.30 | $-20.30 | ▲ 2.00 | $— | $— |
| 2026-06-29 | quarter | 2026-12-31 | $-5.00 | $-7.30 | ▼ 2.30 | $— | $— |
Earnings Call Transcripts
No transcripts available.